NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test
FT. MYERS, Fla., July 24 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer genetics testing services announced today that it has entered into a Strategic Supply Agreement with Abbott
(NYSE: ABT ). The Agreement provides for Abbott
Schmidt & Clark, LLP: FDA Reports Show Abbott Labs Subsidiary Failed to Disclose Parasite Eye Infections Tied to Contact Lens Solution
WASHINGTON, June 22 /PRNewswire-FirstCall/ -- The Washington, D.C.-based law firm of Schmidt & Clark, LLP , is announcing the results of an inspection conducted by the U.S. Food and Drug Administration where investigators determined that a subsidiary of Abbott
Park, Ill.-based Abbott
Feeding America and Abbott Partner For Hurricane Relief Abbott
Donates Relief Supplies to Expedite Immediate Hurricane Response
CHICAGO, May 27 /PRNewswire-USNewswire/ -- Feeding America today announced that it is working with the global health care company, Abbott, to pre-position nutritional products in 20 food banks throughout the Southeast Uni...
Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison
COMMACK, N.Y., April 29 /PRNewswire-FirstCall/ -- It is with great privilege that Avery Biomedical Devices, Inc. (ABD) announces the appointment of Abbott
Krieger, M.D., F.A.C.S. as Chief Clinical Liaison.
Dr. Krieger's expertise with Avery breathing pacemakers began in 1981 while he was Chie...
Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbott's Architect(R) Analyzers
Test may help physicians identify effective treatment earlier
MALVERN, Pa. and Abbott
Park, Ill., Jan. 27 /PRNewswire/ -- Fujirebio Diagnostics, Inc. and Abbott
have signed a license agreement to develop a new ovarian cancer test for use on Abbott's automated ARCHITECT(R) diagnostic analyze...
Rubicon Genomics Announces a Licensing Agreement With Abbott to Develop and Commercialize DNA Methylation Cancer Tests
ANN ARBOR, Mich., Jan. 12 /PRNewswire/ -- Rubicon Genomics today announced a licensing agreement with Abbott, which marks the achievement of significant milestones within their on-going Research and Option Agreement for development and commercialization of Rubicon MethylPlex(TM) methylation detect...
(Multimedia Version): Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management ABBOTT
PARK, Ill., Dec. 15 /PRNewswire-FirstCall/ -- Today, the U.S. Food
and Drug Administration (FDA) approved Abbott's TRILIPIX(TM) (fenofibric acid)
delayed-release capsules for use along with diet to help lower triglycerides
and LDL cholesterol, and to raise HDL cholesterol in patients with...
Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day
Earvin 'Magic' Johnson and Cookie Johnson Public Service Announcement (PSA) focuses on HIV/AIDS and African Americans
PARK, Ill., Dec. 1 /PRNewswire-FirstCall/ -- Today, on the 20th anniversary of World AIDS Day, the Magic Johnson Foundation and Abbott
are calling on the pub...
Now Playing: Spike Lee Stands with Earvin 'Magic' Johnson, Cookie Johnson and Abbott to Launch National PSA Campaign
LOS ANGELES, June 9 /PRNewswire-FirstCall/ -- Today, Earvin "Magic"
Johnson ( http://www.magicjohnson.com/index.php?/foundation/ ), Cookie
( http://www.abbott.com/ ) (NYSE: ABT ) and the Magic Johnson
Foundation launched a public service announcement campaign as part of the
American Diabetes Association Receives $450,000 Grant From Abbott Fund for Latino Community Initiatives
Grant Will Fund Chicago Latino Outreach Program and National Latino Outreach Toolkit
CHICAGO, June 2 /PRNewswire-FirstCall/ -- The American Diabetes
Association (ADA) was recently awarded a $450,000 grant from Abbott
support the ADA's Chicago Latino Outreac...
Abbott in Medical Technology
HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials ABBOTT
PARK, Ill., May 7 /PRNewswire-FirstCall/ -- The Abbott
RealTi m e HIV-1 Assay and Abbott
m 2000 System have been recommended as a standard protocol for viral load testing in HIV/AIDS clinical trials sponsored by the National Institutes of Health (NIH).
This recommendation was ma...
XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
Patients Treated with XIENCE V in SPIRIT III Trial Experience Better
Long-Term Clinical Outcomes, Lower Rates of Stent Thrombosis than Patients Treated with TAXUS
BARCELONA, Spain, May 13 /PRNewswire-FirstCall/ -- Long-term data
presented for the first time today f...
Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and
Effective Treatment to Reduce Risk of Stroke
EXACT and CAPTURE 2 Findings Suggest Improved Outcomes in Carotid
PARK, Ill., March 26, 2007 /PRNewswire-FirstCall/ --
Positive 30-day results from two Abbott
studies confirm that
carotid stenting can be performed with positive results by
physicians with a variety of backgro...
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
...pro forma and GAAP measures, which is explained later in this release.
As a result of selling Isis' diagnostic subsidiary, Ibis Biosciences, to abbott
Molecular Inc. (AMI) in the first quarter of 2009, Isis is reporting Ibis' financial results as discontinued operations. Accordingly, Isis has presen...
Infant Formula Company Teams With the University of Virginia Pediatrics Department to Conduct Clinical Studies
...f Mead Johnson & Co. Similac(R) Advance(R) are registered trademarks of abbott
Laboratories. PBM store-brand formula is neither made by nor affiliated with Mead Johnson or abbott
Contact: Joe Shields
Director of P...
Lower Extremity Peripheral Vascular Stent and Balloon Catheter Markets to Exceed $180 Million in Europe by 2013
...e years to come."
MRG's European Markets for Peripheral Vascular Devices 2009 report provides coverage of key industry competitors, including abbott
Vascular, Boston Scientific, Cook Medical, Cordis, C. R. Bard, Medtronic Vascular, Terumo Medical, W. L. Gore, and many more.
About Millennium R...
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
...abeled Xience V(R) Everolimus-Eluting Coronary Stent System manufactured by abbott
and distributed by Boston Scientific. Xience V is a trademark of the abbott
Laboratories group of companies.
Boston Scientific is a worldwide develop...
Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent
...abeled XIENCE V(R) Everolimus-Eluting Coronary Stent System manufactured by abbott
and distributed by Boston Scientific. XIENCE V is a trademark of the abbott
Laboratories group of companies. Cypher is a trademark of Cordis Corporati...
ePharmaSolutions' Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award
...ch users from 107 countries for the top 20 pharmaceutical companies in the world.
"To be selected along side such companies as Wyeth, GSK, Merck, abbott
and AstraZeneca is truly an honor," said Enrico DePaolis, President & Chief Operating Officer for ePharmaSolutions. "Our teams have been working ...
New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management
...e-FirstCall/ -- Data from a new study showed that abbott
's TRILIPIX(R) (fenofibric acid) delayed-release c...ipix_pi.pdf . Visit www.trilipix.com or call abbott
Medical Information at 1-800-633-9110 for more information about TRILIPIX.
Abbott in Medical Products
Streck-Sheath WBC Reagent
Description:... Use Streck-Sheath to count and classify white blood cells on the abbott
CELL-DYN® 3000, 3500 and 3700. The shelf life is two years from date of manufacture...
Streck-Lysing Agent IIIA Lytic Reagent
Description:... the simultaneous quantitative determination of hemoglobin and white blood cells. Streck-Lysing Agent IIIA is manufactured specifically for use on the abbott
CELL-DYN® 1700. The shelf life is two years from date of manufacture....
Streck-Lysing Agent III Lytic Reagent
Description:...c reagent manufactured for the simultaneous quantitative determinations of hemoglobin and white blood cells. Streck-Lysing Agent III is for use on the abbott
CELL-DYN® 1400 and 1600. The shelf life is two years from date of manufacture....
Streck-Kleen Concentrate Enzymatic Cleanser
Description:... A concentrated enzymatic cleanser manufactured for automated and semi-automated hematology instruments. It is for use on all abbott
CELL-DYN® hematology analyzers, non-differential and differential instruments. The shelf life is 16 months from date of manufacture....
Streck-Hemoglobin/Lyse Lytic Reagent
Description:... Streck-Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the abbott
CELL-DYN® 3000. The shelf life is two years from the date of manufacture....
Streck-CD3500 Hemoglobin/Lyse Lytic Reagent
Description:... Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the abbott
CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent CD Balanced Electrolyte Solution
Description:... Streck-Diluent CD is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the abbott
Streck-Diluent III Plus Balanced Electrolyte Solution
Description:... Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the abbott
CELL-DYN® 3000, 3500 and 3700. The shelf life is two years from date of manufacture....
Streck-Diluent III Balanced Electrolyte Solution
Description:...d sizing. Streck-Diluent III is for use on the Coulter® Counter S Plus JR, ST, JS, JT, S-Plus IV, V, VI with three-part differential and STKR, and abbott
CELL-DYN® 1400 and 1600. The shelf life is two years from date of manufacture....
Streck-Diluent IIIA Balanced Electrolyte Solution
Description:... Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the abbott
CELL-DYN® 1700. The shelf life is one year from date of manufacture....
Abbott in Biological News
University of Texas at Austin engineer elected to American Academy of Arts and Sciences
...imes daily. The technology, the core of ThearSense's Freestyle, was quickly adopted for more than a billion painless glucose assays each year. In 2004 abbott
Laboratories acquired TheraSense, including FreeStyle and the continuous glucose-monitoring FreeStyle Navigator technologies and patents.
"I was fo...
CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda
..., Ph.D., Director, Statistics, Biomarker Research, abbott
Nicholas C. Dracopoli, Ph.D., ...s, Global Pharmaceutical Research and Development, abbott
Linda C. Surh, M.D., Ph.D., FRCPC, Dir...Group Leader, Cellular & Molecular Toxicology, abbott
David Wholley, Director, Biomarkers Co...
NJIT seminar set for Nov. 6 to focus on bioelectronics -- emerging research area
...c and therapeutic uses for patients. And they will outline available educational paths, careers and research opportunities.
David Jamieson, from abbott
Laboratory, opens the set with a look at careers. Haim Grebel, PhD, http://www.njit.edu/publicinfo/newsroom/grebel_bio.php will talk about the opti...
Collegiate Inventors Competition recognizes top student inventors
...he Presenting Sponsors of the 2008 Collegiate Inventors Competition are the abbott
Fund, the philanthropic foundation of the global health care company Abbott...tret microphone). In addition, the judging panel will include experts from abbott
and the USPTO.
Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
...es and HER-2 for use with tamoxifen therapy.
Other companies covered in the GEN article include Myriad Genetics, Genomic Health, Genoptix, Luminex, abbott
Labs, Aureon, Autogenomics, Nanosphere, Navigenics, Osmetech, and Perlegen Sciences.
American Society for Microbiology honors Steven A. Rosenberg
...08The 2008 American Society for Microbiology (ASM) abbott
Laboratories Award in Clinical and Diagnostic Immu...hool of Medicine and Health Sciences. Sponsored by abbott
Laboratories Diagnostics Division, this award reco...h.D. in Biophysics from Harvard University.
Laboratories Award in Clinical and Diagnostic Immu...
American Society for Microbiology honors Bernard Roizman
...nt Award is being presented to Bernard Roizman, Joseph Regenstein Distinguished Service Professor of Virology, The University of Chicago. Sponsored by abbott
Laboratories, this is ASM's premier award for sustained, remarkable contributions to the microbiological sciences.
Dr. Roizman has been a leader in...
July 2008 highlights
...remain unclear. Although genetic predispositions
likely exist, environmental causes have also been suggested. In
an article on p. 154 of this issue, abbott
and coworkers provide
evidence in a primate model that prenatal exposure to androgens,
which are elevated in women with PCOS during late gestation, ...
Genetic Engineering & Biotechnology News reports on cancer biomarkers
... article include those at Sienna Cancer Diagnostics, Geron, Quest Diagnostics Nichols Institute, Gentel Biosciences, Celera, University of Washington, abbott
Laboratories, Strategic Diagnostics, Plasma Proteome Institute, and Biosite.
The Lancet publishes first clinical trial data of a fully bioabsorbable drug eluting stent
PARK, Ill., March 13, 2008 Data published today in The Lancet from ABSORB,... artery that is healed to function as it did before it became diseased."
is the only company with a fully bioabsorbable drug eluting coronary stent ...
Abbott in Biological Technology
Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories
HORSHAM, Pa., June 29 /PRNewswire/ -- Centocor Ortho Biotech Inc. announced today that a federal jury has returned a verdict of $1.67 billion against Abbott
Laboratories in a patent infringement suit.
"We are pleased that the jury has ruled in our favor in the patent litigation case against A...
HUYA Bioscience Announces Strategic Alliance With Abbott on Drug and Biomarker Development Candidates From China
Collaboration will leverage HUYA's growing Chinese bioscience network
SAN DIEGO, April 21 /PRNewswire/ -- HUYA Bioscience International, a leader in US/China pharmaceutical co-development, today announced an agreement with Abbott
to identify and pursue proprietary preclinical and clinical d...
Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences
CARLSBAD, Calif., Dec. 17 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals,
Inc. (Nasdaq: ISIS ) announces the following webcast:
What: Abbott's exercise of its option to purchase Ibis Biosciences,
a subsidiary of Isis. Total acquisition price will be
Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
WARSAW, Ind., Sept. 4 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc.
(NYSE: ZMH ; SWX: ZMH) announced that certain of its subsidiaries have
agreed to acquire the Abbott
Spine business from Abbott
$360 million in cash. Zimmer said it expects to fund the purchase price
ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase
TUCSON, Ariz., April 23 /PRNewswire-FirstCall/ -- ImaRx Therapeutics,
Inc. (Nasdaq: IMRX ) today announced that it has entered into an agreement
Laboratories pursuant to which it has satisfied its obligations
under its $15 million non-recourse promissory note with Abbott
Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
COLUMBIA, Md., October 8 /PRNewswire-FirstCall/ -- Martek Biosciences
Corporation announced today that it has entered into a long-term supply
agreement with Abbott
Nutrition, a leading worldwide producer of infant
formula products including the Similac(R) Advance(R) brand. Martek will
Wisconsin court affirms damages in Innogenetics, Abbott patent case
Madison, Wis. - The United States District Court for the Western District of Wisconsin has upheld a $7 million damage verdict against Abbott
The Madison-based court affirmed the damage award to Innogenetics , a biopharmaceutical company based in Gent, Belgium, and rejected Abb...
A prognosis for GE and Abbott Diagnostics
What is more important: diagnostics, therapeutics, or prognosis? While all are important, we will in this column see how past history has addressed this question and also how recent events, such as GE's acquisition of Abbott's diagnostics units, shed light on this fundamental issue.
It is ...
Promega Announces Agreement with Abbott
will distribute nucleic acid extraction products that will be manufactured by Promega.
Financial details of the agreement were not disclosed.
The Abbott/Promega collaboration will provide a system to purify and extract viral RNA from patient samples using Abbott's novel ...
Prix Galien USA Announces 2009 Final Candidates
United Therapeutics, REMODULIN(R)
Wyeth, Prevnar (R)
Best Medical Device:
Vascular, XIENCE (R)
Boston Scientific, TAXUS (R)
DCA Design, Lantus(R)( )SoloSTAR(R)
GlaxoSmithKline, Veramyst(R)( )Mistpro(TM)
Abbott in Biological Definition
Full blood count
...hey may be identified incorrectly, and not be as accurate as a manual count.
Automated blood counting machines include the Sysmex XE-2100 and the abbott
Manual blood count
Counting chambers that hold a specified volume of diluted blood (as there are far too many cells if it is ...